<DOC>
	<DOCNO>NCT01873989</DOCNO>
	<brief_summary>This study design develop effective treatment intervention chronic pain , symptomatic hypogonadism , opioid addiction</brief_summary>
	<brief_title>Testosterone Replacement Male Opioid Agonist Maintained Patients</brief_title>
	<detailed_description>This study aim assess initial efficacy testosterone replacement male opioid agonist patient symptomatic hypogonadism chronic pain . The study two specific aim : 1 . To estimate , male opioid agonist maintain patient , prevalence ( ) symptomatic hypogonadism ( b ) co-occurring symptomatic hypogonadism chronic pain . 2 . To conduct pilot randomize clinical trial obtain data regard feasibility , acceptability , efficacy ( compare waitlist control ) testosterone replacement male patient POD symptomatic hypogonadism treat opioid agonist maintenance treatment ( N=40 ) .</detailed_description>
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Behavior , Addictive</mesh_term>
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Analgesics , Opioid</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Between 18 50 year age Male buprenorphine methadonemaintained patient APT Foundation Moderate severe chronic pain Meet criterion symptomatic hypogonadism Understand English Interested receive testosterone replacement Current suicide homicide risk Lifethreatening unstable medical condition Known suspect prostate chest cancer history polycythemia</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Chronic pain</keyword>
	<keyword>Opioid addiction</keyword>
	<keyword>Symptomatic hypogonadism</keyword>
	<keyword>Testosterone replacement</keyword>
	<keyword>Opioid agonist maintenance</keyword>
	<keyword>Methadone</keyword>
	<keyword>Buprenorphine</keyword>
</DOC>